Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 7;39(12):187.
doi: 10.1007/s12032-022-01789-7.

Coronary artery disease and cancer: a significant resemblance

Sudeshna Rakshit  1 , Geetha Shanmugam  1 , Koustav Sarkar  2
Affiliations
Review

Coronary artery disease and cancer: a significant resemblance

Sudeshna Rakshit et al. Med Oncol. .

Abstract

Cancer and coronary artery disease (CAD) are two of the most common causes of death, and they frequently coexist, especially as the world's population ages. CAD can develop prior to or following cancer diagnosis, as well as a side effect of cancer treatment. CAD develops as complex interactions of lifestyle and hereditary variables, just like the development of the most complex and non-communicable diseases. Cancer is caused by both external/acquired factors (tobacco, food, physical activity, alcohol consumption, epigenetic alterations) and internal/inherited factors (genetic mutations, hormones, and immunological diseases). The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated protein 9 (Cas9) system has recently emerged as a strong tool for gene therapy for both cancer as well as CAD treatment due to its great accuracy and efficiency. A deeper understanding of the complex link between CAD and cancer should lead to better prevention, faster detection, and safer treatment strategies.

Keywords: CRISPR; Cancer; Coronary artery disease; Epigenetics; Gene therapy; Genetics.

PubMed Disclaimer

References

    1. Fuster V, Voûte J. MDGs: chronic diseases are not on the agenda. Lancet. 2005;366(9496):1512–4. https://doi.org/10.1016/S0140-6736(05)67610-6 . - DOI - PubMed
    1. Coebergh JW, Janssen-Heijnen ML, Post PN, Razenberg PP. Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993–1996. J Clin Epidemiol. 1999;52(12):1131–6. https://doi.org/10.1016/s0895-4356(99)00098-0 . - DOI - PubMed
    1. Tapia-Vieyra JV, Delgado-Coello B, Mas-Oliva J. Atherosclerosis and Cancer; a resemblance with far-reaching implications. Arch Med Res. 2017;48(1):12–26. https://doi.org/10.1016/j.arcmed.2017.03.005 . - DOI - PubMed
    1. Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133(11):1104–14. https://doi.org/10.1161/CIRCULATIONAHA.115.020406 . - DOI - PubMed - PMC
    1. Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK. Cancer incidence and mortality, 1973–1995: a report card for the U.S. Cancer. 1998;82(6):1197–207. https://doi.org/10.1002/(sici)1097-0142(19980315)82:6%3c1197::aid-cncr26... . - DOI - PubMed

LinkOut - more resources